Search for: "State v. Lilly" Results 421 - 440 of 910
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jan 2023, 7:59 am by Anastasiia Kyrylenko
Upreti first discusses the role of national law in such major IP-related ISDS case, Philip Morris v Uruguay, Eli Lilly v Canada, Bridgestone v Panama, and Einarsson v Canada [also commented by The IPKat here and here]. [read post]
26 Feb 2016, 1:21 pm by Gene Quinn
On Saturday, February 13, 2016, Justice Antonin Scalia of the United States Supreme Court passed away in a hotel room in Texas. [read post]
1 Dec 2017, 6:20 am
The panel discussion was on the doctrine of equivalents following the Actavis v Lilly decision. [read post]
4 Jun 2019, 3:59 am
  Jurisdictional battles in IP were confined to memories of Actavis v Lilly and pan-European DNIs, not, what is essentially, the scope of a damages inquiry. [read post]
28 Mar 2010, 5:07 pm
Chantal writes to inform him as follows: "The almost endless series of olanzapine cases (inter alia Eli Lilly patent EP 0 454 436) has now produced an interesting sequel in the Netherlands. [read post]
4 Apr 2016, 11:21 am
| Actavis v Lilly | EU public consultation on neighbouring rights | Life as an IP Lawyer in San Francisco | Copyright in chess games | Trade surplus and IP | Fujifilm Kyowa Biologics v AbbVie Biotechnology. [read post]
26 Nov 2018, 2:09 am by Miquel Montañá
For example, in its judgment of 12 December 2013 (Case C-493/12 Elli Lilly v. [read post]
3 Sep 2008, 11:29 pm
Carole Migden, D- San Francisco, is another slap at a court decision, this time the state Supreme Court's decision in Olson v. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US:… [read post]